Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 36Neoplasms 8HER2-positive Breast Cancer 4Triple Negative Breast Neoplasms 3Neoplasm Metastasis 3Salivary Gland Neoplasms 2Pathologic Complete Response 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Hematologic Neoplasms 2HER2-positive Early Breast Cancer 2Endometrial Neoplasms 2Colonic Neoplasms 2Anatomic Stage I Breast Cancer AJCC v8 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Resectable HER2-positive Breast Cancer 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms by Site 1Neoplasms by Histologic Type 1Lymphoproliferative Disorders 1Lung Neoplasms 1Liver Neoplasms 1Hemangiosarcoma 1Heart Failure 1

Interventions

Nivolumab 11Oxaliplatin 6Fluorouracil 6Capecitabine 5pembrolizumab 4Paclitaxel 4Leucovorin 4durvalumab 3Radiotherapy 3Folfox protocol 3Drug Therapy 3dehydroftorafur 2Trastuzumab 2Specimen Handling 2Radiation 2Metformin 2Magnetic Resonance Spectroscopy 2Itraconazole 2Irinotecan 2Docetaxel 2Cisplatin 2Carboplatin 2zolbetuximab 1zanidatamab 1trifluridine tipiracil drug combination 1tremelimumab 1trastuzumab deruxtecan 1toripalimab 1tislelizumab 1pertuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Adenocarcinoma Of Esophagus × pertuzumab × Clear all
NCT05188313 2022-06-24

TRAP-2

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 3 Recruiting
376 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡